Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 12, 1998, Pages 1241-1247

  Savarino, V ^a   Mela, G S ^a   Zentilin, P ^a   Bisso, G ^a   Pivari, M ^a   Vigneri, S ^b   Termini, R ^b   Fiorucci, S ^c   Usai, P ^d   Malesci, A ^e   Celle, G ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PANTOPRAZOLE; STOMACH SECRETION INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUODENUM ULCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PH MEASUREMENT; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ACID SECRETION; STOMACH PH;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; ANTI-ULCER AGENTS; BENZIMIDAZOLES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DUODENAL ULCER; ENDOSCOPY; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; OMEPRAZOLE; SULFOXIDES; TIME FACTORS;

EID: 7844246538     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00416.x     Document Type: Article

References (28)

1. Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcer? Gastroenterology 1990; 99: 345-51.
2. Bell NJV, Burget D, Howden CW, et al. Appropriate acid suppression for the management of gastro-oesophageal reflux-disease. Digestion 1992; 51(Suppl. 1): 59-67.
3. Van der Hulst RWM, Keller JJ, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1996; 1: 6-19.
4. The European Helicobacter Pylori Study Group (EHPSG). Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41: 8-13.
5. Simon B, Muller P, Hartmann M, et al. Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of gastric H+K+ATPase inhibitor pantoprazole (BY 1025/SK&F 96022) in healthy volunteers. Z Gastroenterol 1990; 28: 443.
6. Londong W. Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans. Aliment Pharmacol Ther 1994; 8(Suppl. 1): 39-46.
7. Hartmann M, Theiss U, Huber R, et al. Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole. Aliment Pharmacol Ther 1996; 10: 359-66.
8. Mela GS, Savarino V, Malesci A, et al. A new method for improving accuracy of 24-hour continuous intragastric pH-metry. Reflections on physiological and pharmacological studies. Dig Dis Sci 1994; 39: 1416-24.
9. Savarino V, Mela GS, Zentilin P, et al. Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. Scand J Gastroenterol 1989; 24: 434-9.
10. Mela GS, Savarino V, Moretti M, et al. Antimony and glass pH electrodes can be used interchangeably in 24 hour studies on gastric acidity. Dig Dis Sci 1990; 35: 1473-81.
11. Savarino V, Mela GS, Scalabrini P, et al. Continuous 24-hour intragastric pH monitoring: focus on reproducibility in duodenal ulcer patients. Gastroenterol Clin Biol 1986; 10: 826-30.
12. Verdù EF, Armstrong D, Fraser R, et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995; 36: 539-43.
13. Savarino V, Mela GS, Zentilin P, et al. Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy. Dig Dis Sci 1994; 39: 161-8.
14. Savarino V, Mela GS, Zentilin P, et al. The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients. Aliment Pharmacol Ther 1996; 10: 367-72.
15. Koop H, Kuly S, Flüg M, et al. Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects. Eur J Gastroenterol Hepatol 1996; 8: 915-18.
16. Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110: 725-32.
17. Sharma BK, Walt RP, Pounder RE, et al. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut 1984; 25: 957-64.
18. Hemery P, Galmiche JP, Roze C, et al. Low dose omeprazole effects on gastric acid secretion in normal man. Gastroenterol Clin Bio 1987; 11: 148-53.
19. Howden CW, Derodra JK, Burget DW, Hunt RH. Effects of low dose omeprazole on gastric secretion and plasma gastrin in patients with healed duodenal ulcer. Hepatogastroenterology 1986; 33: 267-70.
20. Savarino V, Mela GS, Zentilin P, et al. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. Digestion 1989; 42: 1-6.
21. Lind T, Havelund T, Carlsson R, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997; 32: 974-9.
22. Venables T, Newland R, Patel AC, et al. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997; 32: 965-73.
23. Bate CM, Booth SN, Crowe JP, et al. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Gut 1995; 36: 492-8.
24. 2-RA therapy. Am J Gastroenterol 1996; 91: 1758-65.
25. Corinaldesi R, Valentini M, Belaiche J, et al. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study. Aliment Pharmacol Ther 1995; 9: 667-71.
26. Yeomans ND, Tulassay Z, Juhàsz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with non-steroidal antiinflammatory drugs. New Engl J Med 1998; 338: 719-26.
27. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with non-steroidal antiinflammatory drugs. New Engl J Med 1998; 338: 727-34.
28. Colin-Jones DG. Acid suppression: How much is needed? Adjust it to suit the condition. Br Med J 1990; 301: 564-5.